Pfizer And Auxilium Set Partnership For European Rights To Xiaflex
This article was originally published in The Pink Sheet Daily
Executive Summary
For $75 million upfront plus milestones and royalties, Pfizer gets Xiaflex rights for two indications in 46 countries.